The company said the company's formulations unit in Alathur was
inspected by the US Food and Drug Administration (USFDA) in August
without any adverse observations.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-gets-usfda-inspection-report-for-alathur-unit-with-no-adverse-observations/articleshow/71719443.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment